X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Dr. Reddys with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ADCOCK INGRAM (S. Africa) - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   ADCOCK INGRAM
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
ADCOCK INGRAM
Jun-14
DR. REDDYS LAB/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs2,875357-   
Low Rs1,888258-   
Sales per share (Unadj.) Rs930.2106.3-  
Earnings per share (Unadj.) Rs117.4-26.8-  
Cash flow per share (Unadj.) Rs185.8-22.2-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs844.483.5-  
Shares outstanding (eoy) m166.07168.78-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.62.9 88.5%   
Avg P/E ratio x20.3-11.5 -176.6%  
P/CF ratio (eoy) x12.8-13.9 -92.5%  
Price / Book Value ratio x2.83.7 76.5%  
Dividend payout %17.00-   
Avg Mkt Cap Rs m395,49651,922 761.7%   
No. of employees `00022.04.3 511.7%   
Total wages/salary Rs m33,5623,259 1,029.9%   
Avg. sales/employee Rs Th7,032.84,180.1 168.2%   
Avg. wages/employee Rs Th1,527.9759.1 201.3%   
Avg. net profit/employee Rs Th887.7-1,053.3 -84.3%   
INCOME DATA
Net Sales Rs m154,48217,945 860.9%  
Other income Rs m3,375126 2,685.7%   
Total revenues Rs m157,85718,071 873.5%   
Gross profit Rs m31,782-3,110 -1,022.0%  
Depreciation Rs m11,348775 1,465.2%   
Interest Rs m889486 182.9%   
Profit before tax Rs m22,920-4,245 -540.0%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,858265 1,454.6%   
Profit after tax Rs m19,500-4,522 -431.2%  
Gross profit margin %20.6-17.3 -118.7%  
Effective tax rate %16.8-6.2 -269.4%   
Net profit margin %12.6-25.2 -50.1%  
BALANCE SHEET DATA
Current assets Rs m111,10113,143 845.3%   
Current liabilities Rs m58,9737,395 797.5%   
Net working cap to sales %33.732.0 105.3%  
Current ratio x1.91.8 106.0%  
Inventory Days Days79111 71.5%  
Debtors Days Days94124 76.0%  
Net fixed assets Rs m101,2457,661 1,321.5%   
Share capital Rs m83083 996.2%   
"Free" reserves Rs m139,4060-   
Net worth Rs m140,23614,085 995.6%   
Long term debt Rs m22,0004,950 444.5%   
Total assets Rs m224,65626,608 844.3%  
Interest coverage x26.8-7.7 -346.4%   
Debt to equity ratio x0.20.4 44.6%  
Sales to assets ratio x0.70.7 102.0%   
Return on assets %9.1-15.2 -59.8%  
Return on equity %13.9-32.1 -43.3%  
Return on capital %14.9-19.8 -75.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m69,5690-   
CASH FLOW
From Operations Rs m28,7041,532 1,873.9%  
From Investments Rs m-7,727-470 1,642.9%  
From Financial Activity Rs m-21,3264,492 -474.7%  
Net Cashflow Rs m-3145,554 -5.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.93 Rs / ZAR

Compare DR. REDDYS LAB With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare DR. REDDYS LAB With: VENUS REMEDIES  PLETHICO PHARMA  LUPIN  SUVEN LIFESCIENCES  DR. DATSONS LABS  



Today's Market

Indian Indices End on a Positive Note for Third Straight Day; Yes Bank Falls 5%(Closing)

Indian share markets traded on a positive note most of the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the IT sector.

Related Views On News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound (Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On... (The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

A One Stock Crorepati (Profit Hunter)

Jul 4, 2019

Do you wish you could become a crorepati in the stock market? Read on...

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors (The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance (The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jul 17, 2019 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS